Lowering Drug Costs for American Families Act

This bill would raise the number of drugs Medicare picks for price negotiation each cycle from 20 to 50. It would let private and employer health plans use Medicare's negotiated prices unless they choose to opt out, require negotiators to consider drug prices in six other countries, and repeal changes made to the program by a 2025 law. It would also apply Medicare's inflation rebates, which drug makers pay when prices rise faster than inflation, to drugs sold in the commercial market. Starting in 2027, it would cap yearly out-of-pocket drug costs in private plans at $2,000 for individual coverage and limit insulin costs to $35 or less per 30-day supply with no deductible.

Full text and official record on Congress.gov

Sponsors

• Frank Pallone, Jr. Democrat sponsor
• 60 cosponsors